ciglitazone has been researched along with Pneumonia in 2 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Pneumonia: Infection of the lung often accompanied by inflammation.
Excerpt | Relevance | Reference |
---|---|---|
"Ciglitazone ameliorates the inflammatory response and may reduce lung injury after hemorrhagic shock." | 7.74 | Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock. ( Chima, RS; Denenberg, A; Hake, PW; Mangeshkar, P; Piraino, G; Zingarelli, B, 2008) |
"Ciglitazone ameliorates the inflammatory response and may reduce lung injury after hemorrhagic shock." | 3.74 | Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock. ( Chima, RS; Denenberg, A; Hake, PW; Mangeshkar, P; Piraino, G; Zingarelli, B, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chima, RS | 1 |
Hake, PW | 1 |
Piraino, G | 1 |
Mangeshkar, P | 1 |
Denenberg, A | 1 |
Zingarelli, B | 1 |
Ward, JE | 1 |
Fernandes, DJ | 1 |
Taylor, CC | 1 |
Bonacci, JV | 1 |
Quan, L | 1 |
Stewart, AG | 1 |
2 other studies available for ciglitazone and Pneumonia
Article | Year |
---|---|
Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock.
Topics: Animals; Blood Glucose; Chemokines; Cytokines; Disease Models, Animal; Immunohistochemistry; Inflamm | 2008 |
The PPARgamma ligand, rosiglitazone, reduces airways hyperresponsiveness in a murine model of allergen-induced inflammation.
Topics: Allergens; Animals; Bronchoalveolar Lavage Fluid; Bronchoconstrictor Agents; Disease Models, Animal; | 2006 |